To further characterize the BCi-NS1 cells and determine if they retain characteristics of primary BC, Western analysis was carried out using antibodies against basal cell (KRT5, TP63); secretory cell (MUC5AC); Clara cell (CC10); and ciliated cell (DNAI1) specific markers (Figure 1E). Here, MUC5AC is linked to breast cancer.